KALETRA (80 mg + 20 mg)/ml, solution buvable

Business Listing - September 04, 2021

KALETRA (80 mg + 20 mg)/ml, solution buvable

KALETRA (80 mg + 20 mg)/ml, solution buvable solution buvable orale Autorisation active Procédure centralisée Commercialisée 3/20/2001 ABBVIE DEUTSCHLAND (ALLEMAGNE)

Tags & Categories

active solution autorisation procédure commercialisée orale buvable centralisée abbvie kaletra

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business